The drug, based on the compound larazotide acetate, has received FDA “fast track” designation.
Tag: new treatments
Cell Discovery May Answer Who’s at Risk of Severe Allergic Reaction
A cell that produces an inflammatory immune protein may amplify anaphylaxis.